Stock Ticker

  • Loading stock data...

Save the World Air Announces Results of Shareholder Meeting (ZERO)

The annual shareholder’s meeting for Save the World Air (OTC: ZERO) has successfully taken place on September 21, 2012. The company has just released the minutes of the meeting as well as the results of the shareholder’s decisions taken on the day. The company is fast becoming an industry leader in the field of developing applicable solutions […]

Ready, Set, Go…Cellceutix Prepares for Clinical Trials (CTIX)

In a news release this morning, Cellceutix (OTC: CTIX) updated shareholders on the progress of clinical trials scheduled for its anti-cancer drug, Kevetrin. The trials will be conducted at Harvard’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Earlier in the month, the company had amended the clinical protocol for the drug, which the Institutional Review […]

Cellceutix Announces Commencement of Clinical Trials for Anti-Cancer Drug Kevetrin (CTIX)

Cellceutix (OTC: CTIX) has just made a positive announcement for its shareholders who will be happy to know that the company is all set to start clinical trials for its novel anti-cancer drug Kevetrin. The announcement was made earlier in the day, and the clinical trials will be undertaken at the Harvard Cancer Center’s Dana […]

Traders Look Towards Psoriasis Trials To Clear Investment Complexion (CTIX)

Before the market opened this morning after the Labor Day weekend, Cellceutix (OTC: CTIX) announced that it had selected Dr. Reddy’s Laboratory (NYSE: RDY) to manufacture the drug Purisol for the treatment of psoriasis. Cellceutix plans to commence phase two and three clinical trials upon completion of the manufacturing process. In tests involving mice, Purisol demonstrated […]

Sign Up To Get Our Latest Stocks Alerts